Ichor Holdings (ICHR) director sells 53,908 shares after option exercise

Rhea-AI Filing Summary

Ichor Holdings director Thomas M. Rohrs reported an option exercise and share sale. On February 12, 2026, he exercised options for 53,908 ordinary shares at $22.56 per share, then sold 53,908 shares at a weighted average price of $45.48, with individual sale prices ranging from $43.76 to $46.92. After these transactions, he directly owned 53,024 ordinary shares of Ichor Holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROHRS THOMAS M

(Last) (First) (Middle)

C/O ICHOR HOLDINGS, LTD.

3185 LAURELVIEW CT

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ICHOR HOLDINGS, LTD. [ ICHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares, par value $0.0001	02/12/2026	02/12/2026	M		53,908	A	$22.56	106,932	D
Ordinary Shares, par value $0.0001	02/12/2026	02/12/2026	S		53,908	D	$45.48(1)	53,024	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$22.56	02/12/2026	02/12/2026	M			53,908	(2)	05/14/2026	Ordinary Shares, par value $0.0001	53,908	$0	0	D

Explanation of Responses:

1. The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.76 to $46.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. The option vests as follows: 25% of the option vests on May 14, 2020 and the remainder vests ratably on a quarterly basis over a three year period thereafter.

Remarks:

	/s/ Chase Rosson by Power of Attorney	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ICHR director Thomas Rohrs report?

Thomas M. Rohrs reported an option exercise and share sale. On February 12, 2026, he exercised options for 53,908 ordinary Ichor Holdings shares and then sold 53,908 shares, updating his direct ownership position in the company.

How many ICHR shares did the director sell and at what price?

The director sold 53,908 Ichor Holdings shares. The sale occurred at a weighted average price of $45.48 per share, with individual trade prices ranging from $43.76 to $46.92, as disclosed in the footnote to the filing.

How many Ichor Holdings (ICHR) shares does the director own after the Form 4?

After the reported transactions, the director owns 53,024 shares. Following the exercise of 53,908 options and the sale of 53,908 ordinary shares, Thomas M. Rohrs’ directly held position in Ichor Holdings stands at 53,024 ordinary shares.

What option exercise did the ICHR director report on February 12, 2026?

He exercised an option for 53,908 ordinary shares at $22.56. The derivative position was an option with a $22.56 exercise price, covering 53,908 Ichor Holdings ordinary shares, which were converted into common stock on February 12, 2026.

How did the Form 4 describe the sale price range for ICHR shares?

The sale price was reported as a weighted average. The filing states the 53,908 shares were sold at prices ranging from $43.76 to $46.92 per share, with a weighted average sale price disclosed as $45.48.

What is the vesting schedule of the exercised ICHR stock option?

The option vested over four years starting in 2020. According to the footnote, 25% vested on May 14, 2020, and the remaining portion vested ratably on a quarterly basis over the subsequent three-year period.